Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,850 | 3 | 86.8% |
| Food and Beverage | $429.50 | 27 | 13.1% |
| Education | $4.31 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | $2,895 | 7 | $0 (2017) |
| ABBVIE INC. | $69.45 | 4 | $0 (2024) |
| Biogen, Inc. | $60.25 | 4 | $0 (2022) |
| Corium, LLC | $41.89 | 2 | $0 (2023) |
| PFIZER INC. | $39.34 | 2 | $0 (2024) |
| Allergan, Inc. | $27.78 | 2 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $23.80 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.00 | 1 | $0 (2022) |
| GENZYME CORPORATION | $19.59 | 1 | $0 (2017) |
| Biohaven Pharmaceuticals, Inc. | $15.39 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.26 | 4 | ABBVIE INC. ($54.19) |
| 2023 | $62.33 | 3 | Corium, LLC ($25.80) |
| 2022 | $104.96 | 6 | Biogen, Inc. ($31.95) |
| 2021 | $30.38 | 2 | Biohaven Pharmaceuticals, Inc. ($15.39) |
| 2017 | $3,014 | 16 | Avanir Pharmaceuticals, Inc. ($2,895) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: PAIN | ||||||
| 01/22/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: EYE CARE | ||||||
| 07/27/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/13/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 01/17/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2022 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Neurology | ||||||
| 11/08/2022 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Neuroscience | ||||||
| 10/20/2022 | Corium, LLC | ADLARITY (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 09/03/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PRIMARY CARE | ||||||
| 08/24/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2022 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Neurology | ||||||
| 03/27/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: PRIMARY CARE | ||||||
| 01/09/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/21/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/10/2017 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Central Nervous System | ||||||
| 06/15/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/14/2017 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Education | In-kind items and services | $4.31 | General |
| Category: Migraine | ||||||
| 06/12/2017 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | Cash or cash equivalent | $11.36 | General |
| Category: Neurology | ||||||
| 06/05/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: PDP | ||||||
| 05/17/2017 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Migraine | ||||||
| 05/17/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/15/2017 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $11.61 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 312 | 348 | $51,083 | $22,508 |
| 2022 | 10 | 397 | 456 | $82,436 | $30,966 |
| 2021 | 11 | 483 | 556 | $99,490 | $40,078 |
| 2020 | 13 | 489 | 570 | $98,276 | $38,756 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 75 | 75 | $10,498 | $6,783 | 64.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 55 | 65 | $7,345 | $4,339 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 75 | 82 | $6,068 | $3,393 | 55.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 27 | $11,070 | $2,623 | 23.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $2,388 | $1,687 | 70.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 19 | $4,446 | $1,173 | 26.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 23 | 36 | $4,248 | $1,045 | 24.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 20 | 20 | $3,340 | $843.60 | 25.3% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2023 | 12 | 12 | $1,680 | $621.60 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 88 | 97 | $10,573 | $6,374 | 60.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 52 | 53 | $7,208 | $4,872 | 67.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $15,660 | $3,849 | 24.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 64 | $14,400 | $3,497 | 24.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $12,640 | $3,102 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 64 | 69 | $4,968 | $3,085 | 62.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 27 | 27 | $5,693 | $2,912 | 51.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 35 | 35 | $5,135 | $1,475 | 28.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 25 | 41 | $4,674 | $1,329 | 28.4% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2022 | 11 | 11 | $1,485 | $471.00 | 31.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 90 | 90 | $12,105 | $8,905 | 73.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 87 | 101 | $9,980 | $6,013 | 60.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 26 | $15,080 | $4,026 | 26.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 30 | 30 | $5,652 | $3,934 | 69.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 36 | 54 | $11,718 | $2,993 | 25.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 58 | 62 | $4,228 | $2,668 | 63.1% |
About Dr. Douglas Kaplan, MD
Dr. Douglas Kaplan, MD is a Neurology healthcare provider based in Duluth, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588669253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Kaplan, MD has received a total of $3,284 in payments from pharmaceutical and medical device companies, with $72.26 received in 2024. These payments were reported across 31 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,850).
As a Medicare-enrolled provider, Kaplan has provided services to 1,681 Medicare beneficiaries, totaling 1,930 services with total Medicare billing of $132,307. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Duluth, MN
- Active Since 06/17/2005
- Last Updated 01/27/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1588669253
Products in Payments
- ONZETRA Xsail (Drug) $2,880
- NURTEC ODT (Drug) $53.46
- VUMERITY (Drug) $31.95
- BOTOX (Biological) $31.41
- TYSABRI (Biological) $28.30
- Adlarity (Drug) $25.80
- KESIMPTA (Drug) $23.80
- PAXLOVID (Drug) $21.27
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $19.80
- LEMTRADA (Drug) $19.59
- UBRELVY (Drug) $17.97
- ADLARITY (Drug) $16.09
- QULIPTA (Drug) $15.26
- NUEDEXTA (Drug) $14.58
- EMGALITY (Drug) $13.12
- BOTOX THERAPEUTIC (Biological) $12.79
- XARELTO (Drug) $12.77
- NORTHERA (Drug) $11.61
- NUPLAZID (Drug) $11.47
- Rebif (Biological) $11.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Duluth
Dr. Dong Wang, M.d, M.D
Neurology — Payments: $18,017
Gary Beaver, Do, DO
Neurology — Payments: $4,674
Shawnay Mazell, M.d, M.D
Neurology — Payments: $1,885
Dr. Philip Kennedy, Md, MD
Neurology — Payments: $1,053
Rebecca Meyerson
Neurology — Payments: $653.78
Amber Erickson, Md, MD
Neurology — Payments: $247.79